"Yashoda Hospitals, Secunderabad is one of the leading multi-speciality hospitals in Hyderabad. Over the past three decades, Yashoda Group of Hospitals has provided quality healthcare for the people in their diverse medical needs. The needs of the patients have always guided us towards delivering comprehensive care. We constantly work to provide our patients the best healthcare service by perfectly blending revolutionary technology, best medical expertise and advanced procedures. Our comprehensive health care team of specialized doctors, round-the-clock nursing staff and paramedics are equipped with latest medical innovations and state-of-the-art infrastructure. We provide apt medical diagnosis and treatment for diseases, trauma, emergencies"

During the past decade, Yashoda Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yashoda Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "First Wave BioPharma, Inc." with 1 trials sponsored, "Glenmark Pharmaceuticals Ltd. India" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yashoda Hospital" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Glenmark Pharmaceuticals S.A." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Yashoda Hospital" are "Crohn's Disease" (2 trials), "Asthma" (1 trials), "Colitis, Ulcerative" (1 trials), "Covid19" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Yashoda Hospital" in a lesser frequency.

Most popular intervention types in "Yashoda Hospital" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials), "JNJ-78934804" (2 trials) and "Etrasimod" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yashoda Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Yashoda Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Yashoda Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yashoda Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".